Arthritis in Idiopathic Inflammatory Myopathy: Clinical Features and Autoantibody Associations
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10283506" target="_blank" >RIV/00216208:11110/14:10283506 - isvavai.cz</a>
Výsledek na webu
<a href="http://dx.doi.org/10.3899/jrheum.131223" target="_blank" >http://dx.doi.org/10.3899/jrheum.131223</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.3899/jrheum.131223" target="_blank" >10.3899/jrheum.131223</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Arthritis in Idiopathic Inflammatory Myopathy: Clinical Features and Autoantibody Associations
Popis výsledku v původním jazyce
Objective. To determine the prevalence, distribution, and clinical manifestations of arthritis in a cohort of patients with idiopathic inflammatory myopathies (IIM). Associations with autoantibody status and HLA genetic background were also explored. Methods. Consecutive patients with IIM treated in a single center were included in this cross-sectional study (n = 106). History of arthritis, 68-joint and 66-joint tender and swollen joint index, clinical features of IIM, and autoantibody profiles were obtained by clinical examination, personal interview, and review of patient records. High-resolution genotyping in HLA-DRB1 and HLA-DQB1 loci was performed in 71 and 73 patients, respectively. Results. A combination of patients' medical history and cross-sectional physical examination revealed that arthritis at any time during the disease course had occurred in 56 patients (53%). It was present at the beginning of the disease in 39 patients (37%) including 23 cases (22%) with arthritis prec
Název v anglickém jazyce
Arthritis in Idiopathic Inflammatory Myopathy: Clinical Features and Autoantibody Associations
Popis výsledku anglicky
Objective. To determine the prevalence, distribution, and clinical manifestations of arthritis in a cohort of patients with idiopathic inflammatory myopathies (IIM). Associations with autoantibody status and HLA genetic background were also explored. Methods. Consecutive patients with IIM treated in a single center were included in this cross-sectional study (n = 106). History of arthritis, 68-joint and 66-joint tender and swollen joint index, clinical features of IIM, and autoantibody profiles were obtained by clinical examination, personal interview, and review of patient records. High-resolution genotyping in HLA-DRB1 and HLA-DQB1 loci was performed in 71 and 73 patients, respectively. Results. A combination of patients' medical history and cross-sectional physical examination revealed that arthritis at any time during the disease course had occurred in 56 patients (53%). It was present at the beginning of the disease in 39 patients (37%) including 23 cases (22%) with arthritis prec
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FE - Ostatní obory vnitřního lékařství
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2014
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Rheumatology
ISSN
0315-162X
e-ISSN
—
Svazek periodika
41
Číslo periodika v rámci svazku
6
Stát vydavatele periodika
CA - Kanada
Počet stran výsledku
7
Strana od-do
1133-1139
Kód UT WoS článku
000337106600014
EID výsledku v databázi Scopus
—